Wednesday, October 14, 2026
ExploreSearch
Via News
Via News Knowledge File

Microsoft Corporation

organization80% conf.·synced Oct 13, 2026

Technology company partnering with Shopify for Copilot shopping integration

60
sourced metrics
2266
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Market Cap
4018333942455USD
Oct 12, 2026reference only
Price 52 Week Low
352.83USD
Oct 12, 2026reference only
Stock Price
541.15USD
Oct 12, 2026reference only
Price 52 Week High
542.07USD
Oct 12, 2026reference only
Stock Return Ytd
14.4%
Oct 12, 2026reference only
Shares Outstanding
7425545491.0shares
Jul 23, 2026reference only
Capex
115948000000.0USD
Jun 30, 2026reference only
Operating Income
155237000000.0USD
Jun 30, 2026reference only
Total Liabilities
315989000000.0USD
Jun 30, 2026reference only
Operating Cash Flow
182935000000.0USD
Jun 30, 2026reference only
Cost Of Revenue
106374000000.0USD
Jun 30, 2026reference only
Rd Expense
35562000000.0USD
Jun 30, 2026reference only
Gross Profit
225465000000.0USD
Jun 30, 2026reference only
Revenue
331839000000.0USD
Jun 30, 2026reference only
Total Assets
758376000000.0USD
Jun 30, 2026reference only
Cash
20935000000.0USD
Jun 30, 2026reference only
Net Income
133749000000.0USD
Jun 30, 2026reference only
Stockholders Equity
442387000000.0USD
Jun 30, 2026reference only

Stated objectives

Train 3 million people in AI skills

source
target: 3000000 by 2027-01-01 00:00:00stated

Q2 FY2026 total company revenue target

source
target: 79.5 to 80.6 billion USD stated

Q2 FY2026 Productivity and Business Processes revenue target

source
target: 33.3 to 33.6 billion USD stated

Q2 FY2026 Intelligent Cloud revenue target

source
target: 32.25 to 32.55 billion USD stated

Q2 FY2026 More Personal Computing revenue target

source
target: 13.95 to 14.45 billion USD stated

Increase total AI capacity by more than 80% this year

source
target: 80+ percent increase stated

Roughly double total data center footprint over the next two years

source
target: 2x current footprint by 2027-01-01 00:00:00stated

Scale Fairwater AI superfactories to hundreds of thousands of NVIDIA Vera Rubin Superchips

source
target: hundreds of thousands of Superchips stated

Ensure towns and cities near data center development sites are not adversely affected by electricity costs

source
stated

Enhance cloud and AI infrastructure, cybersecurity, and workforce skills across various industries including healthcare in Poland

source
target: 2.8 billion PLN by 2025-02-01 00:00:00stated

Relationship graph · 2266 connections

Developed by
544
Competes with
446
Covered by
197
Supplies to
195
Invested in
138
Customer of
117
subsidiary of
95
Employs
82
constituent of
NYSE FANG+ Index

Via News coverage

Everyone Plans to Deploy AI Agents. Few Can Show Them Their Own Data.
October 7, 2026
Every Company Plans to Use AI Agents. The Hard Part Is Whether Their Data Is Ready
October 4, 2026
Everyone Plans to Use AI Agents. The Hard Part Is the Data Behind Them, and the Strongest Numbers Are in Chips
October 2, 2026
AI Agents Are Moving Into Banks and Insurers, but Their Access to Trustworthy Data Is Not Keeping Pace
September 29, 2026
Enterprise AI Agents Are Racing Ahead of the Data and Trust Needed to Ground Them
September 29, 2026
Enterprises Are Betting Big on AI Agents Faster Than They Can Prove They're Trustworthy
August 31, 2026
Google Loosens Its AI Watermark Rules Just as the Industry Claims to Be Tightening Them
August 19, 2026
Enterprise AI Agents Face a Data Wall — And a New Generation of Vertical Startups Is Routing Around It
August 15, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com